Tokyo Tape
Sign in
← Jmdc

Quarterly report · Q1

4483.TEDINET S100P0TK
Period2022-04-01 → 2022-06-30
Filed2022-08-12
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥5.8bn2022-04-01 → 2022-06-30Cons.Revenue IFRS
Revenue¥21.8bn2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥4.5bn2021-04-01 → 2021-06-30Cons.Revenue IFRS
Operating income¥1.1bn2022-04-01 → 2022-06-30Cons.Operating profit loss IFRS
Operating income¥823m2021-04-01 → 2021-06-30Cons.Operating profit loss IFRS
Profit before tax¥1.1bn2022-04-01 → 2022-06-30Cons.Profit loss before tax IFRS
Profit before tax¥4.8bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥806m2021-04-01 → 2021-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥765m2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥3.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥538m2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥759m2022-04-01 → 2022-06-30Cons.Profit loss IFRS
Net income¥538m2021-04-01 → 2021-06-30Cons.Profit loss IFRS
Total assets¥63.3bnat 2022-06-30Cons.Assets IFRS
Total assets¥62.1bnat 2022-03-31Cons.Assets IFRS
Total assets¥57.3bnat 2021-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥31.9bnat 2022-06-30Cons.Liabilities IFRS
Total liabilities¥30.9bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥31.4bnat 2022-06-30Cons.Equity IFRS
Net assets / equity¥31.2bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥28.3bnat 2021-06-30Cons.Equity IFRS
Net assets / equity¥28.3bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥31.4bnat 2022-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥31.2bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥28.3bnat 2021-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥10.1bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥13.2bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥17.9bnat 2021-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥19.9bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥1.1bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥3.8bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥805m2021-04-01 → 2021-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥3.2bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥8.1bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥1.3bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥909m2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥2.4bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥1.4bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥13.552022-04-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥57.742021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥9.622021-04-01 → 2021-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥12.732022-04-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥54.162021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥9.032021-04-01 → 2021-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio49.7%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio50.2%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio49.4%at 2021-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥58m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥58m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥90m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue2022-04-01 → 2022-06-30¥910m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue external2022-04-01 → 2022-06-30¥869m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥41m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentsegment profit2022-04-01 → 2022-06-30¥47m
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue2022-04-01 → 2022-06-30¥3.7bn
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue external2022-04-01 → 2022-06-30¥3.7bn
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥17m
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentsegment profit2022-04-01 → 2022-06-30¥1.1bn
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentrevenue2022-04-01 → 2022-06-30¥1.2bn
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentrevenue external2022-04-01 → 2022-06-30¥1.2bn
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentsegment profit2022-04-01 → 2022-06-30¥439m
—segment totalrevenue2022-04-01 → 2022-06-30¥5.8bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥5.8bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥58m
—segment totalsegment profit2022-04-01 → 2022-06-30¥1.6bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥35m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥35m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥74m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue2021-04-01 → 2021-06-30¥782m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue external2021-04-01 → 2021-06-30¥755m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥27m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentsegment profit2021-04-01 → 2021-06-30¥49m
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue2021-04-01 → 2021-06-30¥2.8bn
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue external2021-04-01 → 2021-06-30¥2.7bn
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥8m
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentsegment profit2021-04-01 → 2021-06-30¥858m
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentrevenue2021-04-01 → 2021-06-30¥1.0bn
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentrevenue external2021-04-01 → 2021-06-30¥1.0bn
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentsegment profit2021-04-01 → 2021-06-30¥330m
—segment totalrevenue2021-04-01 → 2021-06-30¥4.6bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥4.5bn
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥35m
—segment totalsegment profit2021-04-01 → 2021-06-30¥1.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 683
ItemContextValueUnit
Equity IFRSCurrentQuarterInstant_ShareCapitalIFRSMember9113000000JPY
Equity IFRSCurrentQuarterInstant_CapitalSurplusIFRSMember12504000000JPY
Equity IFRSCurrentQuarterInstant_TreasurySharesIFRSMember-2000000JPY
Equity IFRSCurrentQuarterInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-5000000JPY
Equity IFRSCurrentQuarterInstant_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Equity IFRSCurrentQuarterInstant_ShareAcquisitionRightsIFRSMember21000000JPY
Equity IFRSPrior1YearInstant_OtherComponentsOfEquityIFRSMember17000000JPY
Equity IFRSPrior1YearInstant_RetainedEarningsIFRSMember9580000000JPY
Equity IFRSPrior1YearInstant_EquityAttributableToOwnersOfParentIFRSMember31170000000JPY
Equity IFRSPrior1YearInstant_NonControllingInterestsIFRSMember-5000000JPY
Equity IFRSPrior1YearInstant31165000000JPY
Profit loss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Profit loss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember765000000JPY
Profit loss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember765000000JPY
Profit loss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-6000000JPY
Profit loss IFRSCurrentYTDDuration759000000JPY
Other comprehensive income IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember3000000JPY
Other comprehensive income IFRSCurrentYTDDuration_RetainedEarningsIFRSMember－JPY
Other comprehensive income IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember3000000JPY
Other comprehensive income IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember－JPY
Other comprehensive income IFRSCurrentYTDDuration3000000JPY
Comprehensive income IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember3000000JPY
Comprehensive income IFRSCurrentYTDDuration_RetainedEarningsIFRSMember765000000JPY
Comprehensive income IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember769000000JPY
Comprehensive income IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-6000000JPY
Comprehensive income IFRSCurrentYTDDuration762000000JPY
Issuance of share acquisition rights ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Issuance of share acquisition rights ss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember－JPY
Issuance of share acquisition rights ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember－JPY
Issuance of share acquisition rights ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember－JPY
Issuance of share acquisition rights ss IFRSCurrentYTDDuration－JPY
Share based payment transactions ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Share based payment transactions ss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember－JPY
Share based payment transactions ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember－JPY
Share based payment transactions ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember－JPY
Share based payment transactions ss IFRSCurrentYTDDuration－JPY
Exercise of share acquisition rights ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember-0JPY
Exercise of share acquisition rights ss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember－JPY
Exercise of share acquisition rights ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember41000000JPY
Exercise of share acquisition rights ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember－JPY
Exercise of share acquisition rights ss IFRSCurrentYTDDuration41000000JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember－JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember－JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember－JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration－JPY
Dividends ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Dividends ss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember-565000000JPY
Dividends ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-565000000JPY
Dividends ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass